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LIPOCORTN 1 (Lcl) is an anti-inflammatory
protein, which, given systemically, inhibits poly-
morphonuclear neutrophil (I’MN) emigration
from the circulation to sites of inflammation;
delivery of Lcl to the inflamed site is ineffective.
We have examined the effect of Lcl on changes
in PMN deformability, and observed a consistent
improvement in the deformability of unstimu-
lated PMN; N-formyl-methionyl-leucyl-phenylala-
nine (fMIa’)-activated cell deformability was
unaltered. A Lcl-induced increase in cell deform-
ability may reduce PMN sequestration so con-
tributing to the anti-migratory effects of systemic
Lcl previously demonstrated in vivo.
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Introduction
Glucocorticoids are powerful anti-inflammatory
drugs capable of modulating both cellular and
soluble components of the inflammatory
response. In this investigation we have studied an
anti-inflammatory, glucocorticoid-inducible
protein, lipocortin 1 (Lcl, annexin 1), which
mediates a number of glucocorticoid actions
including inhibition of PMN emigration to sims
of inflammation. The mechanism of this action
has not been fully elucidated, but could include
effects on PMN rolling adhesion, expression of
adhesion molecules, or diapedesis, since, to
reach a site of inflammation, circulating PMN
must slow down, adhere to the endothelium and
migrate between the endothelial cells.
Most previous studies suggest that glucocorti-
coids and Lcl do not directly alter expression of
PMN or endothelial cell adhesion molecules,2’
an exception being Cronstein and colleagues
4
who demonstrated that glucocorticoids diminish
ELAM-1 and ICAM-1 expression on LPS-stimu-
lated endothelium,
4 although these changes
appear to be both time and stimulus-depen-
dent.3,4
Although the details of extravasation are
thought to vary between the systemic and pul-
monary circulations, a reduction in cell deform-
ability can prolong the transit time of PMN
through the microvasculature,
5 thus increasing
opportunities for selectin-mediated rolling adhe-
sion of PMN to endothelial cells, this being a
prerequisite under shear conditions for the leu-
cocyte firm (CD11/CD18-mediated) adhesion
which is required for PMN emigration.
6 There-
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fore, the aim of the present study was to investi-
gate the effect of Lcl on PMN deformability.
Materials and Methods
Recombinant human Lcl (rhLcl) was the
generous gift of Dr J. L Browning, Biogen Inc.,
Cambridge, MA. PMN populations (n 9; > 96.9 ___
2.2% pure)were harvested from peripheral
venous blood as described previously]
Cell suspensions were pre-incubated with
rhLcl dissolved in PBS containing 1 mg human
serum albumin/ml for 30 min at 37C at a con-
centration of 2 btg/106 cells/ml after which the
cells remained > 98% viable. Lcl binds to human
peripheral blood leukocytes in a dose-dependent
manner; the cell surface binding sites on PMN
are approximately 80% saturated at the con-
centration of Lcl and the temperature used in
the present study.
8 Biologically inactive rhLcl was
used as a control.
Cell deformability was assessed in the pres-
ence and absence of 10
-7 M N-formyl-methionyl-
leucyl-phenylalanine (fMLP), by filtration of PMN
suspensions (1 x 105/ml PBS containing 5%
albumin) at constant flow through a Nucleopore
polycarbonate membrane (5 l.tm diameter
pores).9 The more rigid the cells, the longer they
take to enter and pass through the pores result-
ing in a higher pressure. Hence, the pressure
developed by a cell suspension over 6 min filtra-
tion compared to the pressure of PBS alone was
measured as an indicator of cell deformability.
Statistics: Differences between treatments were
assessed using a one-way analysis of variance
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(ANOVA). The level of significance was p <
0.05.
Results
Following pre-incubation with functional
rhLcl, passive PMN from every subject (n 9)
showed increased deformability compared to
control cells at each time point examined up to
6 min filtration (Fig. 1). However, no change in
PMN deformability was observed in the presence
of biologically inactive rhLcl (6 min pressure;
control, 3.09 +_ 0.68 cm H20; inactive rhLcl, 3.00
+__ 0.24 cm H20; n 5; mean 4- S.E.M.;p >
0.05 ANOVA).
When PMN were stimulated with fMLP (6 rain
presure; fMLP, 8.03 _+. 1.33 crn H20) their
deformability was significantly reduced compared
to unstimulated cells (6 rain pressure; control,
3.09 _+ 0.68 crn H20). Neither pre-incubation
with functional nor inactive rhLcl had a con-
sistent or significant effect on PMN deformability
in the presence of fMLP (6 rnin pressure; fMLP
+ rhLcl, 8.49 + 1.0 cm H20; fMLP + inactive
rhLcl, 10.12 0.7 crn H20; n 5; p > 0.05
ANOVA).
Examination of PMN by light microscopy con-
firmed that no cell aggregation occurred with any
treatment regimen, and thus the pressures gener-
ated were indeed a reflection of cell deform-
ability.
Discussion
In this study we observed that incubation of
passive PMN with rhLcl in vitro resulted in a
consistent increase in cell deformability, which
occurred only when the protein was in its
correct, three-dimensional conformation. The
dimensions of the microvasculature impose a
restraint on PMN passage, particularly in the pul-
monary capillaries.7’ The disparity between the
diameters of circulating PMN (6-8 lam) and the
systemic (6 lm) or pulmonary (5 l.tm) capillaries
require that the cells must deform during capil-
lary transit (reviewed in Reference 10). Thus, the
more deformable the cell, the more rapid the
transit through the capillary beds, the briefer the
contact with the endothelium and the fewer the
opportunities for the PMN to adhere prior to
migrating out of the circulation. Hence, a Lcl-
induced increase in cell deformability may
decrease sequestration of PMN in the capillary
bed; this mechanism could contribute to the
reduction by intravenous Lcl of experimentally
induced neutropenia in viva1
Interestingly, when PMN were activated with
fMLP, Lcl had no effect on cell deformability.
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FIG. 1. Effect of rhLcl on deformability of passive human PMN
isolated from peripheral blood (n =9). rhLcl (2 pg/ml) signifi-
cantly increased the deformability of passive PMN at each of the
time points examined. *untreated cells p < 0.05 (ANOVA).
This is consistent with observations in vivo
which have shown that whilst systemic Lcl
reduces the migration of (passive) circulating
neutrophils, Lcl administered directly to a site
of inflammation has no effect on (activated)
migrated PMN.
11
How Lcl causes the obseeeed change in the
mechanical properties of PMN is currently
unknown. PMN deformability is determined
mainly by the intracellular levels, conformation
and distribution of filamentous (F) actin. Lcl can
bind F-actin
12 and thus might directly modify the
conformation and/or distribution of this cyto-
skeletal protein. However, the effect of Lcl on
PMN deformability may potentially be mediated
by changes in signal transduction since studies
on A549 cells demonstrate that Lcl can inhibit G-
protein-mediated activation of arachidonic acid
release. 13 However, as Lcl treatment did not
affect the deformability of activated PMN in our
study, this mechanism seems less likely to
explain the observation reported here. We plan
to investigate the effect of Lcl on F-actin in PMN
more fully.
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